In summary, the authors found that VDAC1+/− mice, notable for their reduced VDAC1 levels compared with VDAC1+/+ mice, exhibited improved mitochondrial function and synaptic activity, and reduced the expression of several AD-related genes. This evidence concerns the gene VDAC1 and Alzheimer disease.